Preventing Infections After Stem Cell Transplant

The weeks and months after a stem cell transplant bring a distinct, well-mapped pattern of infection risk that shifts as the new immune system takes hold. Understanding that pattern — and knowing which symptoms need immediate attention — is central to getting through recovery safely.

Preventing Infections After Stem Cell Transplant

Key Takeaways

  • Infection risk after a stem cell transplant follows a predictable timeline — CDC divides it into three phases: preengraftment (the first 30 days), postengraftment (day 30–100), and the late phase (beyond day 100) — and the types of infections seen shift from one phase to the next.
  • In allogeneic transplants (donor cells), infection is a leading cause of death; in autologous transplants (a patient’s own cells), it’s a major cause of illness but typically less often fatal, largely because immune recovery is faster.
  • Graft-versus-host disease (GVHD), which only occurs after allogeneic transplant, raises infection risk further — acute GVHD appears within the first 3 months, chronic GVHD at 3 months or later, and chronic GVHD is the main driver of late-phase infection risk.
  • A temperature at or above 100.5°F (38°C), or any new redness or swelling near where a catheter enters the skin, warrants an immediate call to the transplant team — not a wait-and-see approach.
  • Because prior immunity often fades after transplant, revaccination is a standard part of long-term care, following a schedule set by the transplant center.

Understanding Infection Risks After Stem Cell Transplant

A hematopoietic stem cell transplant, or HSCT, rebuilds a patient’s blood-forming system once intensive chemotherapy, and sometimes radiation, has cleared out the diseased cells it was meant to destroy. That preparative treatment is also what leaves patients so vulnerable to infection: it wipes out existing white blood cells, and the new immune system needs time to develop and start working. Mucositis — inflammation and sores in the mouth and digestive tract caused by the preparative regimen — breaks down the body’s natural barriers and gives bacteria, viruses, and fungi a way into the bloodstream, and the central venous catheter used to deliver medications and fluids adds another potential entry point.

CDC guidance developed with transplant specialists divides post-transplant immune recovery into three phases, each with its own typical infections. In the preengraftment phase (the first 30 days), prolonged neutropenia and broken mucous membranes make oral, gastrointestinal, and skin flora the main sources of infection, with Candida and, as neutropenia continues, Aspergillus among the more common pathogens; herpes simplex virus can also reactivate during this window. In the postengraftment phase (day 30 to day 100), impaired cell-mediated immunity takes over as the dominant issue, and herpesviruses — especially cytomegalovirus (CMV) — along with Pneumocystis and Aspergillus become the pathogens to watch for. In the late phase (beyond day 100), autologous recipients usually see their immune function recover fairly quickly, while allogeneic recipients with chronic GVHD remain at risk, particularly for infections from encapsulated bacteria and community-acquired respiratory viruses. Looking at outcomes overall, infection ranks among the top causes of death for those who receive donor (allogeneic) transplants, while for recipients of their own cells (autologous transplants) it’s more often a major source of illness than of death, since immune function tends to bounce back faster in that group.

Key Strategies for Preventing Infections

Preventing infection after a transplant combines prescribed medication with everyday habits, and the transplant team tailors both to the phase of recovery a patient is in. Prophylactic antibiotics, antivirals, and antifungals are prescribed specifically to head off common infections before they start, and taking them exactly as directed matters — skipped doses meaningfully raise risk. Some patients also receive growth-factor medication to shorten how long neutropenia lasts during the highest-risk early weeks. Alongside medication, frequent handwashing with soap and water or an alcohol-based sanitizer, daily bathing, and careful oral and skin care all help keep the body’s own defenses intact while the new immune system catches up.

How to avoid infection after stem cell transplant

Day-to-day precautions matter most in the weeks and months closest to transplant, when the immune system is at its weakest. Practical steps recommended by transplant teams include:

  • Hand hygiene: wash hands often, especially before eating, after using the bathroom, and after touching shared surfaces.
  • Catheter care: keep the area around any catheter clean and dry, and watch closely for redness, swelling, or drainage.
  • Food safety: eat only well-cooked meat, fish, and eggs, wash or peel produce thoroughly, and avoid unpasteurized dairy.
  • Crowd and illness avoidance: limit time in crowded indoor spaces, especially during respiratory virus season, and keep distance from anyone who is sick or was recently given a live vaccine.
  • Medication adherence: take every dose of prescribed prophylactic antibiotics, antivirals, and antifungals as directed.

Pet care also needs some adjustment during this period — the transplant team can advise on safe handling or, in some cases, temporary rehoming, since animals can carry organisms that pose a bigger risk to a suppressed immune system than they would to most people. Any questions about a specific exposure are worth raising with the transplant team directly rather than guessing.

Recognizing Symptoms and When to Seek Help

Because a weakened immune system can let an infection progress quickly, new or worsening symptoms deserve prompt attention rather than a wait-and-see approach. Fever tops the list of symptoms to watch for — clinically, that means 100.5°F (38°C) or above — so keeping a working thermometer on hand and checking in whenever something feels off is a basic part of post-transplant self-care. The transplant team will lay out exactly when to reach them, but these signs usually call for an immediate call:

  • A temperature at or above 100.5°F (38°C), or chills
  • New or worsening pain anywhere in the body
  • Redness, swelling, warmth, or drainage at a catheter site or wound
  • Sore throat, cough, or shortness of breath
  • Diarrhea, nausea, vomiting, or abdominal pain
  • An unusual skin rash or sores
  • Burning or pain when urinating

Because a first fever during the preengraftment phase is usually treated right away rather than waiting to pin down an exact cause, prompt reporting — not waiting to see if a symptom resolves on its own — gives the care team the best chance to intervene early.

Long-Term Infection Management and Follow-Up

Infection risk doesn’t end once the highest-risk early weeks have passed. Full immune recovery can take months to years, and allogeneic recipients who develop chronic GVHD, or who remain on immune-suppressing medication for other reasons, stay at elevated risk well past day 100. Regular follow-up visits let the transplant team track immune recovery, watch for late complications, and adjust prevention measures as a patient’s risk changes over time.

Revaccination is a key part of this long-term picture. Immunity built up before transplant — including from childhood vaccines — commonly fades in the years after HSCT if a patient isn’t revaccinated, so transplant centers follow a structured vaccination schedule to rebuild protection against diseases like influenza and pneumococcal infection; family members and household contacts are often encouraged to stay current on their own vaccines too, to lower the patient’s exposure. Alongside medical care, lifestyle habits — not smoking, limiting alcohol, eating well, and staying active as approved by the care team — support overall recovery. Complementary approaches are sometimes discussed as well, but they’re meant to support conventional care, not substitute for it, and anything new should be cleared with the transplant team first.

Frequently Asked Questions

What is the most common type of infection after a stem cell transplant?

It depends on the phase of recovery. In the first 30 days, bacterial infections tied to the patient’s own oral or gut flora are most common, alongside fungal pathogens like Candida. As the immune system starts to recover, viral infections — particularly CMV and other herpesviruses — become more prominent, and fungal infections such as Aspergillus can occur throughout.

How long am I at risk for infections after a stem cell transplant?

Risk is highest in the first 100 days, but it doesn’t disappear after that. Patients who develop chronic GVHD or who stay on immune-suppressing medication can remain at elevated risk for months or years, so ongoing follow-up with the transplant team is part of standard long-term care.

Can I receive vaccinations after a stem cell transplant?

Yes — and for most patients it’s expected, since a transplant typically wipes out immunity built up from earlier vaccinations. The transplant team sets an individualized revaccination schedule based on how a patient’s immune system is recovering, and following it helps rebuild protection against diseases the patient was previously immune to.

Sources

[EN] Cancer Types

Cancer Clinical Trial Options

Specialized matching specifically for oncology clinical trials and cancer care research.

Your Birthday


By filling out this form, you’re consenting only to release your medical records. You’re not agreeing to participate in clinical trials yet.

Most Recent Article